Mycophenolic acid-β-D-glucuronide solution

Research use only, not for human use.

Mycophenolic acid glucuronide is the glucuronide metabolite of mycophenolic acid in human plasma.

Mycophenolic acid glucuronide is the glucuronide metabolite of mycophenolic acid in human plasma.

Mycophenolic acid glucuronide shows weak IMP dehydrogenase (IMPDH) type II inhibition with an IC50 of 3.3 mg/L.

Mycophenolic acid glucuronide (intraperitoneal injection; 6 mg/mouse; once two days; 6 d) treatment reduces tumor growth in an Ehrlich murine spontaneous adenocarcinoma model. Animal Model:Swiss albino strain mouse implanted with Ehrlich ascites tumor cells Dosage:6 mg/mouse Administration:Intraperitoneal injection; 6 mg/mouse; once two days; 6 d Result:Showed 76.8% tumor inhibition compared to the untreated control.

——

Others

Other Targets

——

——

——

31528-44-6

496.465

C23H28O12

>98% (HPLC)

In Vitro:?DMSO : 33.33 mg/mL (67.14 mM)

COc1c(C)c2COC(=O)c2c(O[C@@H]2OC([C@@H](O)C(O)[C@@H]2O)C(O)=O)c1C\C=C(/C)CCC(O)=O

——

(-20℃)

With Ice Pack

≥ 2 years